Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Serious infection is a concern for patients with psoriasis receiving biologic therapies. We assessed the risk of serious infections for biologics used to treat psoriasis by comparison with a cohort receiving non-biologic systemic therapies in a propensity score-weighted Cox proportional hazards mode...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Invest Dermatol
Hlavní autoři: Yiu, Zenas Z.N., Smith, Catherine H., Ashcroft, Darren M., Lunt, Mark, Walton, Shernaz, Murphy, Ruth, Reynolds, Nick J., Ormerod, Anthony D., Griffiths, Christopher E.M., Warren, Richard B.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5832757/
https://ncbi.nlm.nih.gov/pubmed/29054603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jid.2017.10.005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky